• No appointment to book
  • GPhC-registered pharmacy
  • Clinician-led from the start
  • Follow-up included
  • Discreet, tracked delivery
  • Real people to talk to
Save £10 or £25 off your first weight loss consultation with code FIRSTWL10 or FIRSTWL25

Weight loss · Once-weekly injection

Mounjaro.

Tirzepatide. The dual-action weight loss injection, prescribed properly.

A Mounjaro KwikPen

Single pen

Everyone starts here. Your prescriber steps you up only if it suits you.

£144.29per pen

One pen, four weekly doses

New patient offer

  • Use code FIRSTWL10for £10 off
  • Consultation and dose reviews included
  • No subscription, reorder when your prescriber agrees
  • Next-day tracked delivery

Every price includes your consultation and clinical reviews. Each pen holds four weekly doses. Choose a strength to see its price.

Mounjaro is a prescription-only medicine. A bundle is supplied only where your prescriber agrees the doses in it, and each pen is dispensed at the strength prescribed for you.

Why Mounjaro

How Mounjaro helps you lose weight.

Mounjaro is Eli Lilly’s once-weekly injection, licensed by the MHRA for weight management in adults and recommended by NICE. It is the first medicine to act on both the GIP and GLP-1 receptors, and in the SURMOUNT programme it produced the largest average weight loss recorded for a licensed weight-management medicine.

  • 01

    Dual action.

    Tirzepatide activates two gut-hormone receptors rather than one, quietening appetite and food noise while improving how your body handles blood sugar.

  • 02

    Once a week.

    Inject on the same day each week, at whatever time suits you, with or without food. The pen holds four weekly doses and uses a very fine needle.

  • 03

    Proven results.

    On the 15mg dose, 91% of trial participants lost at least 5% of their body weight and 57% lost 20% or more.

  • 04

    Steady build-up.

    Treatment starts at 2.5mg and steps up every four weeks only if you are tolerating it well. Many people settle below the maximum dose.

Get the highlights.

SURMOUNT-1, 72 weeks

22.5%

average body-weight loss on the 15mg dose, taking it as prescribed.*

1×

a week. The same day each week, any time, with or without food.

6

strengths, stepped up with your prescriber. Everyone starts on 2.5mg.

24 to 48 hours

from your assessment to your first injection.

See the prices

*SURMOUNT-1, 72 weeks on the 15mg dose while taking the medicine as prescribed. Averages: individual results vary.

The evidence

What the SURMOUNT-1 trial showed.

A 72-week phase 3 study of 2,539 adults with obesity or overweight, without diabetes, comparing three doses of tirzepatide with placebo alongside diet and physical activity. These are averages; individual results vary and no treatment can guarantee a specific outcome.

Average body-weight change in the trial

  • Mounjaro 15mg-22.5%
  • Mounjaro 10mg-21.4%
  • Mounjaro 5mg-16.0%
  • Placebo with the same diet and activity-2.4%
91%
lost 5% or more of their body weight
78%
lost 15% or more
57%
lost 20% or more
36%
lost 25% or more

Weight loss over 72 weeks while taking the medicine as prescribed. Including participants who stopped early, the figures were 20.9% (15mg), 19.5% (10mg) and 15.0% (5mg). Threshold figures are for the 15mg dose. Jastreboff AM et al., NEJM 2022;387:205–216.

Your dosing journey

A gradual build-up, exactly as licensed.

Mounjaro starts at 2.5mg and increases by 2.5mg every four weeks, giving your body time to adjust and keeping side effects manageable. Your prescriber agrees the maintenance dose that suits you: 5mg, 10mg and 15mg are all licensed maintenance doses.

  1. Month 1

    2.5mg

    Starting dose, to get used to treatment

  2. Month 2

    5mg

    First maintenance dose

  3. Month 3

    7.5mg

    Only if tolerated well

  4. Month 4

    10mg

    Maintenance dose

  5. Month 5

    12.5mg

    Only if tolerated well

  6. Month 6+

    15mg

    Maximum dose

Doses are only increased if you are tolerating treatment well, and you can stay on a lower dose if it is working for you. The schedule follows the UK Summary of Product Characteristics.

Getting started

Three simple steps.

From your assessment to your first injection in 24 to 48 hours.

  1. 1

    Free online consultation.

    A confidential health questionnaire, completed in minutes. Nothing is charged at this stage.

  2. 2

    Prescriber review.

    A UK prescriber checks your suitability, medical history and current medicines, and confirms your starting dose, usually the same day.

  3. 3

    Discreet delivery.

    Dispensed by Lilly Direct, Eli Lilly's own pharmacy service, and sent next day in plain, temperature-controlled, tracked packaging.

Suitability

Is Mounjaro right for you?

Mounjaro is a prescription weight-management medicine used alongside diet and exercise, not a quick fix. Under its UK licence it is for adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, prediabetes, type 2 diabetes or obstructive sleep apnoea.

Every order begins with a confidential online assessment reviewed by our prescribing team. If Mounjaro is not clinically appropriate for you, we will say so and suggest alternatives. The clinical review is a legal requirement and an important safeguard, not a formality.

Quick check before you start

  • You are an adult (18 or over) living in the UK
  • BMI of 30 or above, or 27 to 30 with a weight-related condition
  • Not pregnant, breastfeeding or planning pregnancy
  • No history of pancreatitis or medullary thyroid cancer
  • Ready to make diet and activity changes alongside treatment

At a glance

Active ingredient
Tirzepatide (GIP and GLP-1)
Doses
2.5mg to 15mg, stepped every four weeks
Form
KwikPen, four weekly doses per pen
Licence
MHRA-licensed, NICE-recommended (TA1026)

Safety

Safety at a glance.

Tirzepatide has been studied in more than 10,000 trial participants and is monitored continuously by the MHRA. Most side effects are gastrointestinal, mild to moderate, and ease as your body adjusts to each dose.

  1. 01

    Eat smaller, lower-fat meals and stay well hydrated to ease nausea, which usually settles within a few weeks of each dose change.

  2. 02

    Mounjaro must not be used in pregnancy and should be stopped at least one month before trying to conceive.

  3. 03

    If you take the contraceptive pill, use a barrier method for four weeks after starting and after each dose increase.

  4. 04

    Seek urgent medical help for severe or persistent abdominal pain, ongoing vomiting or signs of dehydration.

For a full list of side effects, see the patient information leaflet supplied with your pen. Report suspected side effects through the MHRA Yellow Card scheme.

Why Cuva

Safe, regulated care you can trust.

Cuva Health is a pharmacy registered with the General Pharmaceutical Council, operating under the supervision of our Superintendent Pharmacist. Every Mounjaro pen we supply is a genuine, MHRA-licensed medicine sourced through the regulated UK supply chain, prescribed only after clinical review.

  • UK-regulated prescribing

    A GPhC-registered pharmacy supervised by a named Superintendent Pharmacist.

  • Fast online consultation

    Free assessment, reviewed by a UK prescriber, usually within one working day.

  • Discreet delivery

    Next-day delivery from Lilly Direct, Eli Lilly's own pharmacy service, in plain, tracked, temperature-controlled packaging.

  • Human support

    Real people on WhatsApp to help with injections and side effects.

GPhC Registered Pharmacy 9012581LegitScript certifiedNational Pharmacy Association member

Registered Pharmacy GPhC 9012581 · Superintendent Pharmacist Irfan Mahmud (GPhC 2080386)

Mounjaro questions? Ask a pharmacist.

Straight answers about tirzepatide, the consultation, dosing, storage and delivery, written by our clinical team.

Frequently asked

  • What is Mounjaro?

    Mounjaro is the brand name for tirzepatide, a once-weekly prescription injection made by Eli Lilly. It is licensed in the UK for weight management in adults alongside a reduced-calorie diet and increased physical activity, and separately for type 2 diabetes. It comes as a KwikPen containing four weekly doses.

  • How much weight could I expect to lose?

    In the SURMOUNT-1 trial, adults taking the 15mg dose as prescribed lost an average of 22.5% of their body weight over 72 weeks, and 21.4% on 10mg. For someone weighing 100kg that is around 22kg, though results vary from person to person and depend on diet and activity. Your prescriber will discuss realistic goals with you.

  • How does Mounjaro work?

    Tirzepatide mimics two hormones your gut releases after eating, GIP and GLP-1. Together they tell your brain you are full, slow the emptying of your stomach and quieten the constant food noise that makes eating less so difficult. Because it lasts in the body for around a week, one injection keeps a steady effect on appetite.

  • How long will it take to see results?

    Many people notice a smaller appetite within the first week or two. Weight loss builds gradually as the dose steps up, and the trial figures above are measured over 72 weeks. Your prescriber reviews your progress before every dose change.

  • Does Mounjaro affect the contraceptive pill?

    It can. Mounjaro slows stomach emptying, which may reduce how well oral contraceptives are absorbed. Use a barrier method as well for four weeks after starting and for four weeks after each dose increase, or speak to your prescriber about alternatives.

  • How do I inject Mounjaro?

    Once a week, on the same day each week, into the abdomen, thigh or the back of the upper arm, using a very fine needle. Rotate the site each week. Full instructions come with your first order, and the clinical team can talk you through it on WhatsApp.

  • How do I store the pen?

    Keep the pen in the fridge at 2 to 8°C, in its box to protect it from light. It can be kept out of the fridge for up to 30 days below 30°C. Do not freeze it, and do not use a pen that has been frozen.

  • What happens if I miss a dose?

    If it is within four days (96 hours) of the missed dose, take it as soon as you remember and carry on with your usual day. If more than four days have passed, skip it and take the next dose on your usual day. Never take two doses within three days of each other.

  • Is Mounjaro safe?

    It is a licensed medicine, safe for most eligible adults under clinical supervision. The most common side effects are nausea, diarrhoea, constipation and indigestion, usually mild and easing over time. Rarer but serious risks include pancreatitis and gallbladder problems, so seek help quickly for severe or persistent stomach pain. Your medical history is always reviewed before treatment begins.

  • Will I regain weight if I stop?

    Some regain is common after stopping any weight-loss medicine, because appetite returns. The habits built during treatment make a real difference, and your prescriber can plan a gradual step-down with you rather than stopping abruptly.

  • Can I switch to Mounjaro from another treatment?

    Yes. If you are already on a weight-loss medicine, tell us your current medicine and dose during the consultation and upload a photo of your prescription or packaging. Where it is clinically appropriate, your prescriber can start you on an equivalent dose rather than at 2.5mg.

Sources

  1. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM 2022;387:205–216.
  2. NICE. Tirzepatide for managing overweight and obesity (TA1026).
  3. emc. Mounjaro KwikPen Summary of Product Characteristics, sections 4.2, 4.5, 4.8 and 6.4.
  4. MHRA Yellow Card scheme.

Ready when you are.

Start with a short, free online assessment. A UK prescriber takes it from there.

Not for emergencies. Call 999, or NHS 111 for urgent advice.